96438 ⎘
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom Pteridine radicals
MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#2MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#3Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7
#4Anti-microbial agents and uses thereof
#5Selective inhibitors of translesion DNA replication
#6THERAPEUTIC FUROPYRIMIDINES AND THIENOPYRIMIDINES
#7MODIFIED 2' AND 3' NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#8Bicyclic nucleosides and nucleotides as therapeutic agents
#9Hepatitis C therapies
#10Indole derivatives
#11Tricyclic-Nucleoside Compounds for Treating Viral Infections
#12Tricyclic-Nucleoside Prodrugs for Treating Viral Infections
#13Anti-microbial agents and uses thereof
#14Nucleoside compounds and methods of use thereof
#15Selective inhibitors of translesion DNA replication
#16Bicyclic Nucleosides and Nucleotides as Therapeutic Agents
#17Therapeutic furopyrimidines and thienopyrimidines
#18Indole Derivatives
#19Process for preparing a synthetic intermediate for preparation of branched nucleosides
#20Modified 2′ and 3′-nucleoside prodrugs for treating infections
#21Modified 2′ and 3′-nucleoside prodrugs for treating infections
#22Modified 2′ and 3′-nucleoside prodrugs for treating infections
#23Modified 2′ and 3′-nucleoside prodrugs for treating infections
#24Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
#25Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
#26Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#27Modified 2′ and 3′-nucleoside prodrugs for treating infections
#28Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#29Halogenated aminoquinolines and oligonucleotides containing the same
#30Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
#31Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
#32Tricyclic-nucleoside compounds for treating viral infections
#33Hepatitis C therapies
#34Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
#35Tricyclic-nucleoside prodrugs for treating viral infections
#36Indolopyrrolocabazole derivative and antitumor agent
#372-beta -modified-6-substituted adenosine analogs and their use as antiviral agents
#38Fluorescent N,N3-etheno-purine (2′-deoxy) riboside derivatives and uses thereof
#39Therapeutic furopyrimidines and thienopyrimidines
#405-nitro-nucleoside compounds for treating viral infections
#41Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof
#42Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
#43Novel nucleosides and related processes, pharmaceutical compositions and methods
#44Benzodeazaadenine derivative base and electronic material containing the same
#45COMT inhibitors for the treatment of depression and impaired cognition
#46Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
#47Anti-viral 7-deaza D-nucleosides and uses thereof